Literature DB >> 11772818

The use of a human patient simulator in the evaluation of and development of a remedial prescription for an anesthesiologist with lapsed medical skills.

Meg A Rosenblatt1, Kenneth J Abrams.   

Abstract

The New York State Society of Anesthesiologists' Committee on Continuing Medical Education and Remediation has been charged by the Office of Professional Medical Conduct of the New York State Department of Health to develop a remediation program for individuals ordered into retraining. We describe the development of an anesthesiology-specific evaluation to identify areas of deficiency to both determine a candidate's suitability, as well as to facilitate the creation of an appropriate prescription for retraining. A human patient simulator was used to aid in the gathering of information during the evaluation process. Specifically, the use of simulation allowed the exploration of a candidate's preparation, approach to clinical situations, technical abilities, response to clinical problems, ability to problem solve, and accuracy of medical record keeping. Human patient simulation should be considered a valuable tool in the process of evaluating physicians with lapsed medical skills.

Entities:  

Mesh:

Year:  2002        PMID: 11772818     DOI: 10.1097/00000539-200201000-00028

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Patient simulation: a literary synthesis of assessment tools in anesthesiology.

Authors:  Alice A Edler; Ruth G Fanning; Michael I Chen; Rebecca Claure; Dondee Almazan; Brain Struyk; Samuel C Seiden
Journal:  J Educ Eval Health Prof       Date:  2009-12-20

2.  Instructor-based real-time multimedia medical simulation to update concepts of difficult airway management for experienced airway practitioners.

Authors:  Pin-Tarng Chen; Hung-Wei Cheng; Chia-Rong Yen; I-Wen Yin; Ying-Che Huang; Chao-Chun Wang; Mei-Yung Tsou; Wen-Kuei Chang; Huey-Wen Yien; Cheng-Deng Kuo; Kwok-Hon Chan
Journal:  J Chin Med Assoc       Date:  2008-04       Impact factor: 2.743

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.